XRAY DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important January 27 Deadline in Securities Class Action – XRAY

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / WHY: New York, N.Y., January 21, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ:XRAY) between May 6, 2021 and November 6, 2024, both dates inclusive (the "Class Period"), of the important […]

CELH DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Celsius Holdings, Inc. Investors to Secure Counsel Before Important January 21 Deadline in Securities Class Action – CELH

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / WHY: New York, N.Y., January 21, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock and sellers of puts of Celsius Holdings, Inc. (NASDAQ:CELH) between February 29, 2024 and September 4, 2024, both dates inclusive (the "Class

Levi & Korsinsky Reminds Zeta Global Holdings Corp. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 21, 2025 – ZETA

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Zeta Global Holdings Corp. (NYSE:ZETA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zeta-global-holdings-corp-lawsuit-submission-form-2?prid=124168&wire=1 or contact Joseph E. Levi, Esq. via email at

SQ SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Block, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Block, Inc. ("Block" or "the Company") (NYSE:SQ) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for

XRX DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Xerox Holdings Corporation Investors to Secure Counsel Before Important January 21 Deadline in Securities Class Action – XRX

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / WHY: New York, N.Y., January 21, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Xerox Holdings Corporation (NASDAQ:XRX) between January 25, 2024 and October 28, 2024, both dates inclusive (the "Class Period"), of the important January

Investors who Lost Money on Cassava Sciences, Inc. (SAVA) Should Contact Levi & Korsinsky About Pending Class Action – SAVA

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Cassava Sciences, Inc. (NASDAQ:SAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cassava-sciences-inc-lawsuit-submission-form?prid=124171&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Class Action Filed Against Customers Bancorp, Inc. (CUBI) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Customers Bancorp, Inc. (NYSE:CUBI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/customers-bancorp-inc-lawsuit-submission-form?prid=124154&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Shareholders that Lost Money on Revance Therapeutics, Inc. (RVNC) Should Contact Levi & Korsinsky About Pending Class Action – RVNC

NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=124167&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Scroll to Top